Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Catherine C. Fahey"'
Autor:
Douglas B. Johnson, Michael B. Atkins, Cassandra Hennessy, Trisha Wise-Draper, Hannah Heilman, Joy Awosika, Ziad Bakouny, Chris Labaki, Renee Maria Saliby, Clara Hwang, Sunny R. K. Singh, Nino Balanchivadze, Christopher R. Friese, Leslie A. Fecher, James J. Yoon, Brandon Hayes-Lattin, Mehmet A. Bilen, Cecilia A. Castellano, Gary H. Lyman, Lisa Tachiki, Sumit A. Shah, Michael J. Glover, Daniel B. Flora, Elizabeth Wulff-Burchfield, Anup Kasi, Saqib H. Abbasi, Dimitrios Farmakiotis, Kendra Viera, Elizabeth J. Klein, Lisa B. Weissman, Chinmay Jani, Matthew Puc, Catherine C. Fahey, Daniel Y. Reuben, Sanjay Mishra, Alicia Beeghly-Fadiel, Benjamin French, Jeremy L. Warner, COVID-19 and Cancer Consortium
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-9 (2023)
Abstract Introduction COVID-19 particularly impacted patients with co-morbid conditions, including cancer. Patients with melanoma have not been specifically studied in large numbers. Here, we sought to identify factors that associated with COVID-19 s
Externí odkaz:
https://doaj.org/article/69fb2be87d9e4455bca96362eb3128f6
Autor:
Catherine C. Fahey, Caroline A. Nebhan, Sally York, Nancy B. Davis, Paula J. Hurley, Jennifer B. Gordetsky, Kerry R. Schaffer
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 22, p 16109 (2023)
Penile squamous cell carcinoma is a rare disease with very limited data to guide treatment decisions. In particular, there is minimal evidence for effective therapies in the metastatic setting. Here, we present a case of metastatic penile squamous ce
Externí odkaz:
https://doaj.org/article/fb14be73bfc64840a4529b243d029d19
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/b4e39e9a1e7f42519573e1fff43c02b6
Publikováno v:
Expert Review of Anticancer Therapy. :1-11
Autor:
Catherine C. Fahey, Jeffrey W. Shevach, Ronan Flippot, Laurence Albiges, Naomi B. Haas, Kathryn E. Beckermann
Publikováno v:
American Society of Clinical Oncology Educational Book.
Significant strides have been made in the frontline treatment of patients with advanced clear cell renal cell carcinoma (ccRCC). There are multiple standard-of-care doublet regimens consisting of either the combined dual immune checkpoint inhibitors,
Autor:
W. Kimryn Rathmell, Cheryl L. Walker, Ruhee Dere, Joel S. Parker, Brian D. Strahl, Ian J. Davis, Abid Khan, Aguirre A. de Cubas, Yihsuan S. Tsai, Ryoma Ohi, Reid T. Powell, Pratim Chowdhury, Bo-Hwa Sohn, Charles B. Shuster, Menuka Karki, Catherine C. Fahey, Frank M. Mason, Durga Nand Tripathi, Esteban A. Terzo, In-Young Park, Yun-Chen Chiang
Loss of the short arm of chromosome 3 (3p) occurs early in >95% of clear cell renal cell carcinoma (ccRCC). Nearly ubiquitous 3p loss in ccRCC suggests haploinsufficiency for 3p tumor suppressors as early drivers of tumorigenesis. We previously repor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b405439d92a4d44007c6c967ae1a3cf
https://doi.org/10.1158/0008-5472.c.6510453
https://doi.org/10.1158/0008-5472.c.6510453
Autor:
W. Kimryn Rathmell, Cheryl L. Walker, Ruhee Dere, Joel S. Parker, Brian D. Strahl, Ian J. Davis, Abid Khan, Aguirre A. de Cubas, Yihsuan S. Tsai, Ryoma Ohi, Reid T. Powell, Pratim Chowdhury, Bo-Hwa Sohn, Charles B. Shuster, Menuka Karki, Catherine C. Fahey, Frank M. Mason, Durga Nand Tripathi, Esteban A. Terzo, In-Young Park, Yun-Chen Chiang
SETD2 loss promotes chromosomal abnormalities.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68cf572946bacc7499a8f3ac9594ff59
https://doi.org/10.1158/0008-5472.22419723.v1
https://doi.org/10.1158/0008-5472.22419723.v1
Autor:
W. Kimryn Rathmell, Cheryl L. Walker, Ruhee Dere, Joel S. Parker, Brian D. Strahl, Ian J. Davis, Abid Khan, Aguirre A. de Cubas, Yihsuan S. Tsai, Ryoma Ohi, Reid T. Powell, Pratim Chowdhury, Bo-Hwa Sohn, Charles B. Shuster, Menuka Karki, Catherine C. Fahey, Frank M. Mason, Durga Nand Tripathi, Esteban A. Terzo, In-Young Park, Yun-Chen Chiang
fig legends for sup figures
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14971053ddde6dac6e1a07f8b4f7587d
https://doi.org/10.1158/0008-5472.22419699
https://doi.org/10.1158/0008-5472.22419699
Autor:
Brian D. Strahl, Pratim Chowdhury, Ryoma Ohi, W. Kimryn Rathmell, Bo Hwa Sohn, A. Ali Khan, Catherine C. Fahey, Aguirre A. de Cubas, Cheryl Walker, Frank M. Mason, Charles B. Shuster, Menuka Karki, Ruhee Dere, Durga Nand Tripathi, Yun Chen Chiang, Ian J. Davis, Esteban A. Terzo, In Young Park, Reid T. Powell, Joel S. Parker, Yi-Hsuan Tsai
Publikováno v:
Cancer Research. 78:3135-3146
Loss of the short arm of chromosome 3 (3p) occurs early in >95% of clear cell renal cell carcinoma (ccRCC). Nearly ubiquitous 3p loss in ccRCC suggests haploinsufficiency for 3p tumor suppressors as early drivers of tumorigenesis. We previously repor
Autor:
Deepak Kumar Jha, Catherine C. Fahey, Andy H. Vo, Yun Chen J. Chiang, Julia V. DiFiore, Kathryn E. Hacker, Stephen A. Shinsky, Ian J. Davis, Brian D. Strahl, W. Kimryn Rathmell, Jordan A. Shavit
Publikováno v:
Journal of Biological Chemistry. 291:21283-21295
The yeast Set2 histone methyltransferase is a critical enzyme that plays a number of key roles in gene transcription and DNA repair. Recently, the human homologue, SETD2, was found to be recurrently mutated in a significant percentage of renal cell c